Home/Filings/4/0001209191-13-000296
4//SEC Filing

Utterberg David S 4

Accession 0001209191-13-000296

CIK 0001333170other

Filed

Jan 1, 7:00 PM ET

Accepted

Jan 2, 7:15 PM ET

Size

9.4 KB

Accession

0001209191-13-000296

Insider Transaction Report

Form 4
Period: 2012-12-31
Utterberg David S
Director10% Owner
Transactions
  • Award

    Common Stock

    2012-12-31$11.25/sh+888$9,9903,931,150 total
  • Sale

    Common Stock

    2013-01-02$11.29/sh26,532$299,4913,904,618 total
  • Sale

    Common Stock

    2012-12-31$11.15/sh9,669$107,8343,930,262 total
Footnotes (4)
  • [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2010, amended on March 11, 2011, and further amended on August 15, 2012.
  • [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $11.00 to $11.31. The reporting person undertakes to provide to the issuer, any holder of the issuer's stock, or the SEC, upon request, full information regarding the number of shares sold at each separate price within the range described above.
  • [F3]Pursuant to the issuer's director compensation policy, non-employee directors may elect to receive shares of the issuer's common stock in lieu of cash compensation payable pursuant to such policy. Payments of common stock in lieu of cash compensation are made quarterly in the amount of the total cash compensation earned by a non-employee director during such quarter divided by the closing price of the issuer's common stock on the last day of the quarter. The closing price of the issuer's common stock on December 31, 2012, the last trading day of the quarter, was $11.25.
  • [F4]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $11.11 to $11.53. The reporting person undertakes to provide to the issuer, any holder of the issuer's stock, or the SEC, upon request, full information regarding the number of shares sold at each separate price within the range described above.

Issuer

NxStage Medical, Inc.

CIK 0001333170

Entity typeother

Related Parties

1
  • filerCIK 0001341407

Filing Metadata

Form type
4
Filed
Jan 1, 7:00 PM ET
Accepted
Jan 2, 7:15 PM ET
Size
9.4 KB